Colorado Medical Board: News


Board Work Group Meeting - Dec. 5

The Board Member Work Group that is working on revisions to the Policy for Prescribing and Dispensing Opioids will meet to review stakeholder feedback and make necessary revisions to the proposed draft. This meeting is open to the public and the agenda will include a public comment period.

Meeting Information

Two Ways to Participate

  1. In Person: Civic Center Plaza, 1560 Broadway, Conference Room 1250 C, Denver, CO 80202.
  2. By Webinar: Register at the following link: https://attendee.gotowebinar.com/register/3020151020581800706

Prior Stakeholder Meeting Recordings Available

The Division of Professions and Occupations hosted two stakeholder meetings on October 27 and November 14 in Denver to discuss potential updates to the Policy for Prescribing and Dispensing Opioids.

These forums follow four previous Community Meetings held in Pueblo, Greeley and Denver over the past year.


​Sunset Review Begins

The Colorado Office of Policy, Research and Regulatory Reform (COPRRR) is conducting a sunset review of the Colorado Medical Board. Analysis in a sunset review is performed to determine whether the regulatory program is necessary and should be continued, modified or eliminated. This review will produce a report with recommendations to the Colorado General Assembly and result in subsequent legislation based on the recommendations in the report.

Your input is an important component of a successful sunset review. If you would like to submit comments online, please submit the COPRRR online comment form


Newsletter Fall Issue Available

Be sure to review the latest version of the Colorado Medical Board Pulse. Get updated on the latest rule and policy changes as well as PDMP information and an introduction to your new Program Director.


Rulemaking Hearing - Nov. 16

The Colorado Medical Board will hold a public rulemaking hearing on Thursday, November 16, 2017 regarding amendments to Rule 280. 

The Board encourages interested parties to submit written comments to the following address: Paula Martinez, Program Director, Colorado Medical Board, 1560 Broadway, Denver, CO 80202 or via electronic mail to paula.martinez@state.co.us regarding any of the above listed rulemaking matters no later than Friday, October 13, 2017.

In addition, at the time and place designated in this notice, the Board will afford interested parties an opportunity to submit written information, data, views or arguments. The board will also afford interested parties an opportunity to make brief oral presentations, unless the Board in its discretion determines that such oral presentations are unnecessary. All submissions will be considered. The rules under consideration may be changed or modified after public comment and hearing.


Important PDMP Updates

As we work together to tackle prescription drug misuse, abuse and diversion, we see PDMP utilization rates continue to increase as the database continues to serve as an important tool for meeting the standard of care for safe prescribing.

New Website

We are pleased to announce a new and improved PDMP website: colorado.gov/dora-pdmp. We listened to your challenges and ideas and hope you’ll find the new website easier to navigate and more relevant to your needs. You will be able to link to your PDMP account and access other information directly from the homepage. We also selected a new vendor, APPRISS, and will be utilizing the PMP AWARxE system. The database interface will look different and make PDMP queries easier and quicker. We encourage your continued feedback for ongoing improvement efforts.

New State Law Improves Access to PDMP

To make the PDMP more accessible and easier for health professionals to incorporate into daily use, the Colorado General Assembly passed legislation in 2017. On April 6, 2017, Governor John Hickenlooper signed Senate Bill 17-146 Access To Prescription Drug Monitoring Program, which clarifies health professionals' access to the PDMP database by:

  • Allowing a health care provider with prescribing authority to query the PDMP about a current patient, including checking on drug interactions and side effects, thus making the PDMP an even more useful tool for health professionals in their clinical decision-making for patients;
  • Allowing a veterinarian with prescribing authority to query the PDMP about a current client if the veterinarian has a reasonable basis to suspect the client has committed drug abuse or has mistreated an animal; and
  • Allowing a pharmacist to query the PDMP about a current patient for whom the pharmacist is dispensing any prescription drug, rather than only patients receiving controlled substances.

The law became effective immediately, and the Division is working with the appropriate Boards to implement the new law including rulemaking, outreach and education. If you have questions about the Colorado PDMP, please contact Division staff at 303-894-5957 or pdmpinqr@state.co.us. If you need technical assistance with the PMP AWARxE system, please contact the vendor help desk at 1-855-263-6403.


October 16 Rule 400 Stakeholder Recording

The Colorado Medical Board held a stakeholder meeting on Monday, October 16, 2017 to address proposed revisions to Colorado Medical Board Rule 400.

Colorado law permits agencies to formally solicit views from interested stakeholders concerning proposed draft rules before commencing the formal rulemaking process. Stakeholders were invited to share thoughts and recommendations as we finalize the draft of the proposed revisions to Rule 400. 

If you have any questions or concerns, please contact the Colorado Medical Board at dora_medicalboard@state.co.us


Cost-Benefit Analysis

A member of the public may email the Office of Policy, Research and Regulatory Reform to request a cost-benefit analysis from the agency proposing rule changes, which is made publicly available when completed. In performing a cost-benefit analysis, each rulemaking entity must provide the information requested for the cost-benefit analysis to be considered a good faith effort. The cost-benefit analysis must be submitted to the Office of Policy, Research and Regulatory Reform at least ten (10) days before the administrative hearing on the proposed rule and posted on the agency's website. For all questions, please attach all underlying data that supports the statements or figures stated in this cost-benefit analysis.


Free Access to PainNET System for Colorado Providers

The Colorado Department of Health Care Policy and Financing (HCPF) has worked with the vendor of its Project ECHO Pain Management Program, Community Health Center, to expand access to the program website known as PainNET.

The PainNet website is an online learning community that aims to improve pain care expertise among primary care providers. The website is also now available to other Health First Colorado (Colorado’s Medicaid Program) primary care medical providers (PCMPs) for free.

The PainNET learning community enables PCMPs to develop expertise to treat patients with complex chronic pain through a combination of archived Project ECHO Pain case presentations, resource libraries, community forums and expert consultations. Providers and specialists are able to communicate through discussion boards, chat rooms and direct messaging.

This is a great resource for Colorado providers to access resources that can increase their knowledge on how to manage chronic pain more effectively.

Learn More About PainNET


Serve as a Consultant to the Colorado Medical Board

Experts assist the Board by providing reviews and opinions on Board cases. This is an excellent opportunity to give back to your profession, help your community, and gain valuable experience. To learn more about the application process, contact dora_medicalboard@state.co.us or download the Consultant Application.


Colorado Consortium for Prescription Drug Abuse Prevention

Stay up to date on the latest guidelines, training and resources for the management of chronic pain patients, and the safe use, safe storage, and safe disposal of prescription medications to help reduce prescription drug abuse in Colorado.